OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Semaglutide vs Endoscopic Sleeve Gastroplasty for Weight Loss
Muhammad Haseeb, Jagpreet Chhatwal, Jade Xiao, et al.
JAMA Network Open (2024) Vol. 7, Iss. 4, pp. e246221-e246221
Open Access | Times Cited: 29

Showing 1-25 of 29 citing articles:

GLP-1 single, dual, and triple receptor agonists for treating type 2 diabetes and obesity: a narrative review
Nasreen Alfaris, Stephanie W. Waldrop, Veronica Johnson, et al.
EClinicalMedicine (2024) Vol. 75, pp. 102782-102782
Open Access | Times Cited: 29

Medical therapy to treat obesity and optimize fertility in women of reproductive age: a narrative review
Janelle Duah, David B. Seifer
Reproductive Biology and Endocrinology (2025) Vol. 23, Iss. 1
Open Access | Times Cited: 4

IFSO Bariatric Endoscopy Committee Evidence-Based Review and Position Statement on Endoscopic Sleeve Gastroplasty for Obesity Management
Barham K. Abu Dayyeh, Christine Stier, Aayed Alqahtani, et al.
Obesity Surgery (2024)
Open Access | Times Cited: 10

Emerging Pharmacotherapies for Obesity: A Systematic Review
Michail Kokkorakis, Marlene Chakhtoura, Caline Rhayem, et al.
Pharmacological Reviews (2024) Vol. 77, Iss. 1, pp. 100002-100002
Open Access | Times Cited: 9

Cardioprotective benefits of metabolic surgery and GLP-1 receptor agonist–based therapies
Arianne Morissette, Erin E. Mulvihill
Trends in Endocrinology and Metabolism (2024)
Closed Access | Times Cited: 5

Efficacy of Revisional Endoscopic Sleeve Gastroplasty After Laparoscopic Sleeve Gastrectomy
John Deng, Julia Wool, Ronald Blanco Montecino, et al.
Obesity Surgery (2025)
Open Access

Addressing the obesity epidemic through safe and effective endoscopic bariatric therapies
Sven Adamsen
Gastrointestinal Endoscopy (2025) Vol. 101, Iss. 3, pp. 537-538
Closed Access

Incidence of new onset arterial hypertension after metabolic bariatric surgery: an 8-year prospective follow-up with matched controls
Viiko Vahtera, Jukka Pajarinen, Mika Kivimäki, et al.
Journal of Hypertension (2025)
Closed Access

Dual and Triple Gut Peptide Agonists on the Horizon for the Treatment of Type 2 Diabetes and Obesity. An Overview of Preclinical and Clinical Data
Ioanna A. Anastasiou, Georgia Argyrakopoulou, Μaria Dalamaga, et al.
Current Obesity Reports (2025) Vol. 14, Iss. 1
Open Access

Impact on Metabolism Generated by Surgical and Pharmacological Interventions for Weight Loss in Women with Infertility
Paulo César Gete Palacios, Alberto Moscona-Nissan, Renata Saucedo, et al.
Metabolites (2025) Vol. 15, Iss. 4, pp. 260-260
Open Access

Unveiling the Cost-Effectiveness of Bariatric Surgery: Insights from a Matched Cohort Study
Samuel Lloyd, Elizabeth Wall‐Wieler, Yuki Liu, et al.
Surgery for Obesity and Related Diseases (2025)
Closed Access

New Generation Anti-Obesity Pharmacotherapy: Companion or Competitor to Metabolic Bariatric Surgery?
Amirhossein Sahebkar, Kishore M. Gadde, Matthew Kroh, et al.
Drug Discovery Today (2024) Vol. 29, Iss. 8, pp. 104072-104072
Closed Access | Times Cited: 3

Position statement and guidelines about Endoscopic Sleeve Gastroplasty (ESG) also known as “Endo-sleeve”
Clément Baratte, Hugues Sebbag, Laurent Arnalsteen, et al.
Journal of Visceral Surgery (2025)
Open Access

Obesity management for the treatment of type 2 diabetes: emerging evidence and therapeutic approaches
Arianne Morissette, Erin E. Mulvihill
Journal of Pharmacy & Pharmaceutical Sciences (2024) Vol. 27
Open Access | Times Cited: 2

Bariatric Surgery Is Associated with Lower Concentrations of Fecal Secondary Bile Acids and Their Metabolizing Microbial Enzymes: A Pilot Study
Hisham Hussan, Mohamed R. Ali, Victoria Lyo, et al.
Obesity Surgery (2024) Vol. 34, Iss. 9, pp. 3420-3433
Closed Access | Times Cited: 1

Bariatric and Metabolic Surgery in the Adult Population
Betemariam Sharew, Nandan Kodur, Ricard Corcelles, et al.
Mayo Clinic Proceedings (2024) Vol. 99, Iss. 10, pp. 1631-1645
Closed Access | Times Cited: 1

Pre-Procedural Predictors of Successful Endoscopic Sleeve Gastroplasty: A Retrospective Study
Lior Charach, Noam Peleg, Ran Abuhasira, et al.
Gastroenterology Insights (2024) Vol. 15, Iss. 2, pp. 459-470
Open Access

Medical weight loss in older persons with obesity
Alessandro Gavras, John A. Batsis
Clinical Obesity (2024) Vol. 14, Iss. 5
Closed Access

The Best of Endoscopic Bariatric and Metabolic Therapies 2024
Shelby Sullivan
Gastrointestinal Endoscopy (2024) Vol. 100, Iss. 6, pp. 994-996
Closed Access

Approaches to patients with obesity and CKD: focus on nutrition and surgery
Vincenzo Bellizzi, Giuseppe Annunziata, Alice Albanese, et al.
Clinical Kidney Journal (2024) Vol. 17, Iss. Supplement_2, pp. 51-64
Open Access

Bariatric arterial embolization slows gastric emptying and improves postprandial glycaemia in obese dogs with impaired glucose tolerance
Zhi Wang, Qing‐Yue Cao, Chunjie Xiang, et al.
Diabetes Obesity and Metabolism (2024) Vol. 26, Iss. 10, pp. 4490-4500
Open Access

Why Bariatric and Metabolic Endoscopy Matters Today
Violeta Popov, Shelby Sullivan
Gastrointestinal Endoscopy Clinics of North America (2024) Vol. 34, Iss. 4, pp. xv-xvi
Closed Access

Page 1 - Next Page

Scroll to top